ROR1 and precursor B-cell acute lymphoblastic leukemia: To assess the scope of mAb-based therapies targeting cell surface ROR1 in pediatric B-ALL, we next investigated antigen-mediated internalization, a prerequisite for antibody-drug conjugates and immunotoxins.